-transparent.png){kind=logo}
Gene therapy of cancer includes strategies for augmentation of immunotherapeutic and chemoterapeutic approaches. These strategies mainly involve ex vivo and in vivo cytokine gene transfer, drug sensitization with genes for prodrug delivery, and the use of drug-resistance genes for protecting bone marrow from high-dose chemotherapy (1). Vector development remains the primary focus for any future research in the field. Retroviral vectors, especially those derived from Moloney murine leukemia virus (MoMLV), remain among the most widely utilized vectors in gene therapy trials.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
G Palù, and
M Pizzato, and
R Bonaguro, and
F Colombo
January 2009,
Methods in molecular biology (Clifton, N.J.),
G Palù, and
M Pizzato, and
R Bonaguro, and
F Colombo
October 2005,
Cancer gene therapy,
G Palù, and
M Pizzato, and
R Bonaguro, and
F Colombo
October 2000,
No shinkei geka. Neurological surgery,
G Palù, and
M Pizzato, and
R Bonaguro, and
F Colombo
March 2011,
The journal of gene medicine,
G Palù, and
M Pizzato, and
R Bonaguro, and
F Colombo
January 1998,
Advances in experimental medicine and biology,
G Palù, and
M Pizzato, and
R Bonaguro, and
F Colombo
February 2001,
Chinese medical journal,
G Palù, and
M Pizzato, and
R Bonaguro, and
F Colombo
November 2000,
No shinkei geka. Neurological surgery,
G Palù, and
M Pizzato, and
R Bonaguro, and
F Colombo
May 2007,
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
G Palù, and
M Pizzato, and
R Bonaguro, and
F Colombo
September 1999,
Zhonghua zhong liu za zhi [Chinese journal of oncology],
G Palù, and
M Pizzato, and
R Bonaguro, and
F Colombo
March 1997,
World journal of gastroenterology,
